Sarcomas

Enhanced Recovery After Surgery in Extremity Sarcoma

National Clinical Trial ID:: NCT04461171(opens in a new tab)
Protocol ID:: VICCSAR2020
Primary Investigator:: Joshua Lawrenz
Phase:: N/A
Age Group:: Adults
Genders Eligible:: All
Cancer Type:: Sarcomas

Overview

The purpose of this study is to demonstrate the efficacy of implementing the enhanced recovery after surgery (ERAS) pathway in a prospective manner to patients undergoing surgical treatment for extremity sarcoma.

Detailed Description

Specifically, the focus of this study will be regarding the administration of a perioperative non-narcotic, multimodal pain management pathway. Primary endpoints collected with be short-term patient reported outcomes (pain scores [PROMIS] and [QoR-15]), limb function scores [MSTS], and key clinical outcomes (hospital length of stay, opioid requirements/prescribing data and perioperative complications).

Who Can Participate

Inclusion Criteria

Any patient at Vanderbilt University Medical Center treated with surgical excision of a suspected extremity sarcoma

Adult patients >17 years of age

Patients of all preoperative opioid status (naïve or dependent)

Exclusion Criteria

Patients treated non-operatively

Non-English speaking patients

Disclaimer

This summary is based on publicly available information from clinicaltrials.gov and is intended to help patients discuss possible trial options with their oncology care team. ClinicalTrials.gov and related public listings do not independently review or approve the safety and scientific merit of every study.

Participation decisions can be made only after review by the study team and your treating clinician.